Friday, July 10, 2026

pharma · Extensive-stage Small Cell Lung Cancer · Gastric Cancer

Shanghai Medical College

Fudan University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Extensive-stage Small Cell Lung Cancer, Gastric Cancer, Hodgkin Lymphoma, Cancer of Unknown Primary Site. NovaPharmaN

CN HQ
20 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
20
Programs
4
Drugs
3
Patents
0
Clinical program

IGEV

Phase 2 · small molecule · Hodgkin Lymphoma

IGEV for Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Fudan University with 1 ClinicalTrials.gov record(s).

← All Fudan University projects Phase 2 small molecule active

Internal code LMTG 11-02

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Fudan University
Phase
Phase 2
Modality
small_molecule
Indication
Hodgkin Lymphoma
Status
active
Trials
1

Clinical trials